Medicare Enrolled
Dr. Constantinos Costeas, M.D.
Cardiovascular Disease · West Orange, NJ
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Costeas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Costeas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Costeas
Dr. Constantinos Costeas is a cardiovascular disease specialist in West Orange, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Costeas performed 4,879 Medicare services across 3,511 unique beneficiaries.
Between the years covered by Open Payments, Dr. Costeas received a total of $14,333 from 51 pharmaceutical and/or device companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Costeas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in NJ
$14,333 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,879
Medicare services
Top 16% in NJ for cardiovascular disease
3,511
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~244 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
1,102 | $7 | $46 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
595 | $19 | $136 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
455 | $101 | $757 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
417 | $12 | $92 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
417 | $23 | $164 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
341 | $72 | $533 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
289 | $65 | $481 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
194 | $27 | $203 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
177 | $18 | $124 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
176 | $68 | $432 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
170 | $29 | $201 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
60 | $75 | $601 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
59 | $92 | $652 |
| Cardiac rhythm monitor programming Adjustment and configuration of an implanted cardiac rhythm monitoring device to ensure proper operation and data collection. |
58 | $45 | $348 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $105 | $722 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $137 | $897 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
28 | $37 | $304 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
27 | $53 | $395 |
| Programming of single lead implantable defibrillator system Adjustment and testing of the settings for a single-lead implantable cardioverter-defibrillator (ICD) to ensure proper function. |
26 | $63 | $485 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
26 | $59 | $474 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
21 | $44 | $374 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
20 | $429 | $2,585 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
19 | $52 | $436 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
18 | $21 | $147 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
16 | $94 | $933 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
16 | $45 | $297 |
| Repair of left upper heart chamber with implant A surgical procedure to repair the left upper chamber of the heart using an implanted device, with review by a radiologist. |
13 | $439 | $4,252 |
| Pacemaker/ICD evaluation at implant or replacement Assessment of a single or dual chamber pacing cardioverter-defibrillator and generator during the initial implantation or replacement procedure. |
13 | $153 | $1,807 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
12 | $16 | $118 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
11 | $69 | $25,088 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
35.8% high complexity
0.0% medium
64.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,333
Total received (2018-2024)
Avg $2,048/year across 7 years
Top 15% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
490
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,320 (99.9%)
Other
Charitable contributions, space rental, and other categories
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,394
2023
$1,724
2022
$1,421
2021
$491
2020
$2,437
2019
$4,353
2018
$2,513
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$433
Novartis Pharmaceuticals Corporation
$253
Medtronic, Inc.
$149
Merck Sharp & Dohme LLC
$97
E.R. Squibb & Sons, L.L.C.
$94
PFIZER INC.
$52
Janssen Pharmaceuticals, Inc
$46
Alnylam Pharmaceuticals Inc.
$44
SANOFI-AVENTIS U.S. LLC
$44
iRhythm Technologies, Inc.
$41
AstraZeneca Pharmaceuticals LP
$32
Impulse Dynamics (USA) Inc.
$22
Cleerly, Inc.
$19
Kestra Medical Technology Services, Inc.
$18
SCPHARMACEUTICALS INC.
$17
Amgen Inc.
$17
ATRICURE, INC.
$16
Top 3 companies account for 59.9% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$4,321
Medtronic Vascular, Inc.
$2,807
Novartis Pharmaceuticals Corporation
$1,461
Abbott Laboratories
$876
BOSTON SCIENTIFIC CORPORATION
$617
Merck Sharp & Dohme LLC
$439
Janssen Pharmaceuticals, Inc
$395
PFIZER INC.
$392
E.R. Squibb & Sons, L.L.C.
$339
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$320
SANOFI-AVENTIS U.S. LLC
$249
Amgen Inc.
$193
Lundbeck LLC
$180
Medtronic, Inc.
$178
Alnylam Pharmaceuticals Inc.
$140
Edwards Lifesciences Corporation
$119
Amarin Pharma Inc.
$105
AltaThera Pharmaceuticals LLC
$101
ShockWave Medical, Inc
$100
iRhythm Technologies, Inc.
$78
Biosense Webster, Inc.
$72
AtriCure, Inc.
$68
Lexicon Pharmaceuticals, Inc.
$56
CARDIVA MEDICAL, INC.
$56
AstraZeneca Pharmaceuticals LP
$47
DAVOL INC.
$47
Kiniksa Pharmaceuticals, Ltd.
$42
Kestra Medical Technology Services, Inc.
$39
Bayer HealthCare Pharmaceuticals Inc.
$39
Relypsa, Inc.
$39
SCPHARMACEUTICALS INC.
$35
Philips Electronics North America Corporation
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Novo Nordisk Inc
$30
Arbor Pharmaceuticals, Inc.
$29
Kowa Pharmaceuticals America, Inc.
$29
CVRx, Inc.
$25
Impulse Dynamics (USA) Inc.
$22
Cleerly, Inc.
$19
G Medical Diagnostic Services, Inc.
$19
ATRICURE, INC.
$16
Cardinal Health 200, LLC
$15
Esperion Therapeutics, Inc.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Merck Sharp & Dohme Corporation
$14
Eisai Inc.
$13
Baxter Healthcare
$13
Cardinal Health 200 LLC
$13
Welch Allyn
$12
ARBOR PHARMACEUTICALS, INC.
$12
Sensible Medical Innovations Inc
$10
Top 3 companies account for 59.9% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (CK4) MCOT · AMVUTTRA · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE SYNERGY ABLATION SYSTEM · AURORA EV-ICD MRI SURESCAN · AZURE XT DR MRI SURESCAN · Advisa · Advisor Catheter · Anthem CRT Pacemaker · Arcalyst · Assure WCD · Assurity Pacemaker · AtriCure Cryosurgical System · Azure · Barostim Neo System · CAMZYOS · CAPSUREFIX NOVUS MRI SURESCAN · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · COBALT DR MRI SURESCAN · CRT-Ps · Cardiac Monitoring Suite · Carto 3 System · Claria MRI · Cleerly Ischemia · Connect HF · Consulta · Corlanor · ELIQUIS · ENTRESTO · Edarbi · EnSite Velocity System Expansion Modules · FARXIGA · FORTIFY ASSURA · FUROSCIX · GENERAL THERAPIES · GENERAL THERAPIES · GENERAL TACHY · GENERAL THERAPIES · General - Therapies · Hillrom - Cardiac Ambulatory Monitor · Inpefa · JARDIANCE · KAPSPARGO · Kerendia · LEQVIO · LINQ II · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MICRA · MULTAQ · MYCARELINK · MYNX CONTROLTM · Micra · NEXLETOL · NORTHERA · None · ONPATTRO · Optimizer · PRO CV · PROGEL · PULSESELECT · Pentaray · Performa · RESONATE · ReDS system · Repatha · Reveal LINQ · Rybelsus · SAPIEN 3 Ultra RESILIA · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY · Safire Blu and Safire Blu Cath · Solara · Sotalol Hydrochloride · Tryton Side Branch Stent · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
1,596
Per 100K population
186.9
County median income
$76,712
Nearest hospital
HACKENSACK MERIDIAN MOUNTAINSIDE MEDICAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Costeas is an electrophysiology & remote specialist, with above-average Medicare volume (top 16% in NJ), with low-engagement industry engagement in the top 15% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Costeas experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Costeas performed 1,102 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Costeas receive payments from pharmaceutical companies?
Yes. Dr. Costeas received a total of $14,333 from 51 companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Costeas's costs compare to other cardiologists in West Orange?
Dr. Costeas's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Costeas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in West Orange
Browse cardiologists in West Orange ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology